Feature Article | Biotech’s Missing Ingredient: Execution

In this guest post for Life Science Daily News, Leen Kawas argues that biotech's real bottleneck isn't scientific, it's operational. Drawing on patterns she's seen across the industry, she breaks down why strong clinical data alone doesn't create a successful therapy, and what founders and investors need to get right before the data even reads out.

Read the Full Article